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ABSTRACT
Objectives: The study measured the concentrations of antioxidants in women during pregnancy and the Post 
Partum Period (PPP) with a view to investigating their role in the aetiology of pregnancy induced hypertension 
(PIH).
Study Design: Informed consent was obtained from 105 women who were divided into three groups: 15 age and 
parity matched normotensive non-pregnant (control group), 45 normotensive and 45 hypertensive pregnant 
women. The two groups of pregnant women were divided into three groups of 15 each and studied in the second 
and third trimesters and PPP respectively. Venous blood was obtained from all the participants for measurements 
of some antioxidants (uric acid, albumin, catalase and vitamin C). Data were analyzed using descriptive and 
inferential statistical methods.
Results: The results show that the mean concentrations of catalase, albumin, vitamin C and uric acid for the 
control were 3.1 ± 0.18 µ/l, 46.6 ± 6.6 g/l, 0.38 ± 0.01 mg/dl and 0.16 ± 0.03 mmol/l respectively. The mean 
concentration of all antioxidants except uric acid were significantly lower during pregnancy when compared with 
controls (t= 2.06; p<0.01). In the normotensive group of pregnant women, vitamin C was the only antioxidant that 
showed significant higher concentration when the second trimester concentration and third trimester 
concentration were compared (t=2.06; p<0.05). Uric acid levels were significantly higher (t=2.06; p<0.05) and 
nd rdcatalase and vitamin C levels were significantly lower in the hypertensive group during the 2  and 3  trimesters 
(t=2.06; p<0.05). There was a tendency for all antioxidant concentrations to return to normal values during the 
PPP in the normotensive group; however in the hypertensive group, uric acid levels remained significantly higher 
(t=2.06; p<0.05).
Conclusion: In conclusion this study showed that pregnancy generally reduced the concentration of antioxidants 
but vitamin C levels were higher in late pregnancy of normotensive women. Therefore higher levels of vitamin C 
may protect against PIH.
Keywords: Antioxidants, Normal Pregnancy, Pregnancy Induced Hypertension (PIH).
INTRODUCTION 
Pre-eclampsia is associated with maternal and 
perinatal morbidity and mortality in the developed 
and developing economy.  Aetiology of pre-
eclampsia is yet unknown despite many theories. 
The role of antioxidant in its etiology is currently 
receiving attention worldwide. There is 
increasing evidence that an imbalance of 
increased oxidative stress, lipid peroxidation 
associated with deficiency of antioxidant 
protection contributes to the endothelia cell 
damage and dysfunction which is associated with 
1-3this pregnancy disorder . Free radicals are highly 
4
reactive molecules , excess or high levels of it in 
the body will lead to tissue damage through 
oxidative stress and lipid peroxidation, which in 
turn could lead to complications such as 
hypertension. Antioxidants such as catalase, 
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superoxide dismutase, ß-carotene, vitamin C and 
E,  glutathione/glutathione peroxidase,  
ceruloplasmin, and transferin are present 
throughout the body in the cells, cell membranes, 
lipoproteins and extracellular fluids, where they 
5combat oxidative stress . 
Available evidence confirms that there is increase 
oxidative stress in normal pregnancy but with 
6,7increased antioxidant protection . Whereas in 
pregnancy induced hypertension there is no 
proportional increase in the antioxidants to 
counteract the level of oxidative stress 
8-10
experienced. . Levels of plasma antioxidants 
are measured as indices of free radical status, 
since free radicals are difficult to measure directly. 
This study is designed to investigate the status of 
ascorbic acid, catalase, uric acid and albumin in 
pregnancy induced hypertensions (PIH). The 
study examined the status and role of these 
antioxidants in patients with pregnancy induced-
hypertension by comparing the plasma status in 
non-pregnant healthy women (control), 
normotensive pregnant women and PIH patients 
in Osun state, Nigeria. 
MATERIALS AND METHODS:
The study was conducted at the Department of 
Obstetrics and Gynaecology, Obafemi Awolowo 
University Teaching Hospitals Complex (Wesley 
Guild Hospital, Ilesa and Ife State Hospital, Ile-
Ife) Osun State, Nigeria. Informed consent was 
obtained from 105 women who were divided into 
three groups: 15 age and parity matched 
normotensive non-pregnant (control group), 45 
normotensive and 45 hypertensive pregnant 
women. The two groups of pregnant women were 
divided into three groups of 15 each and studied in 
the second and third trimesters and three to six 
days postpartum period (PPP) respectively. Ethics 
and research committee approval was obtained. 
The diagnosis of pre-eclampsia and PIH were 
established in accordance with the ACOG 
11definitions . Diastolic blood pressure was taken 
with a cuff sphygmomanometer according to the 
fifth Korotkoff sound. The presence of proteinuria 
was screened with the dipstick Albustix method 
(Ames Division, Miles Laboratories Limited, 
England) and the amount of protein was measured 
in a 24-hour urine sample. The presence of 
oedema was established by physical examination.
 Uric acid, albumin, catalase and ascorbate 
antioxidants were investigated. They were 
nd rdestimated in the 2  and 3  trimesters and three to 
six days postpartum period (PPP). Correlation 
be tween  t he se  measu red  pa r ame te r s  
(antioxidants) and the values of the blood 
pressure in pregnancy within each trimester were 
also studied. The results were also compared with 
that obtained for the 15 non-pregnant 
normotensive women matched for age and parity. 
Patient with chronic hypertension with super 
imposed pre-eclampsia were excluded from the 
study, samples were taken before any medications 
were started and before any attempt at delivery 
while postpartum samples were taken three to six 
days postpartum. Peripheral venous blood 
samples were collected into heparinized 
vacutainer tubes and centrifuged at 2500rpm for 
o10minutes at 4 C to separate the plasma. The 
plasma was then put into plain tubes and frozen at 
o–20 c until analyses. Plasma ascorbic acid 
concentrations were assayed within 24 h in order 
to prevent changes of level. All the parameters 
were estimated in plasma. Plasma total ascorbic 
acid levels were assayed spectrophotometrically 
by the 2,4-dinitrophenylhydrazine method 
12 described by Henry et al (1974).) Uric acid was 
estimated by TPTZ method as described by Morin 
13
Prox (1973) . Albumin was estimated by the 
bromocreso green (BCG)/succinate buffer 
14
system as documented by Doumas et al (1972) . 
Catalase assay method was modified from 
Experimental Biochemistry Laboratory Manual, 
Department of Biochemistry, University of 
15
Wisconsin, (1967)
The data obtained for each of the antioxidant in 
the different groups were subjected for statistical 
analyses using SPSS statistical software package 
(SPSS Inc., Chicago, USA) version 11.0. 
Analysis of variance (ANOVA), student t-test and 
the Pearson correlation coefficients were used. 
The results were accepted to be significant when P 
value was less than 0.05. All values are expressed 
as mean and standard deviation.
RESULTS
The clinical characteristics and the mean and 
standard deviation values of the plasma 
concentrations of uric acid, albumin, catalase, and 
vitamin C in the three groups of women are seen 
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in tables 1&2. The mean maternal age and parity 
did not differ significantly among the groups. The 
results show that the mean concentrations of 
catalase, albumin, vitamin C and uric acid for the 
control were 3.1 ± 0.18 µ/l, 46.6 ± 6.6 g/l, 0.38 ± 
0.01 mg/dl and 0.16 ± 0.03 mmol/l respectively. 
The mean concentration of all antioxidants except 
uric acid were significantly lower during 
pregnancy when compared with controls (t= 2.06; 
p<0.01). In the normotensive group of pregnant 
women, vitamin C was the only antioxidant that 
showed significant higher concentration when the 
second trimester concentration and third trimester 
concentration were compared (t=2.06; p<0.05). 
Uric acid levels were significantly higher (t=2.06; 
p<0.05) and catalase and vitamin C levels were 
significantly lower in the hypertensive group 
nd rd
during the 2  and 3  trimesters (t=2.06; p<0.05). 
There was a tendency for all antioxidant 
concentrations to return to normal values during 
the PPP in the normotensive group; however in the 
hypertensive group, uric acid levels remained 
significantly higher (t=2.06; p<0.05).
DISCUSSION
Our study has shown that the plasma 
concentrations of catalase and vitamin C were 
significantly decreased in second trimester 
normotensive pregnant women than non–pregnant 
normotensive. The significant decreases in 
catalase and vitamin C may suggest that in normal 
pregnancies, these antioxidants may have been 
excessively consumed because of their activity in 
16-18
removing excess free radicals. Several studies  
have confirmed that decreased antioxidants in 
maternal circulation show that women with 
normal pregnancies have increased oxidative 
stress, lipid peroxidation and also increased 
antioxidant protection that offsets the oxidative 
stress when compared with non pregnant women. 
The mean plasma catalase and ascorbate 
antioxidants levels of the second and third 
trimesters and postpartum period of hypertensive 
pregnant women were significantly (p<0.001) 
lower than those of second and third trimesters and 
3-6 day postpartum period in normotensive 
pregnant women respectively. This result further 
confirms the findings of other workers that 
antioxidants are highly reduced in hypertensive 
than in normotensive subjects and that as the 
hypertensive pregnancy progresses, the decreases 
in plasma levels of catalase and vitamin C become 
9-10, 19-20
worse .
There was no significant change in plasma 
albumin concentrations in non-pregnant 
nd
normotensive women when compared with 2  
trimester normotensive pregnant women. There is 
a decrease in albumin in second and third 
trimester hypertensive pregnancy respectively 
but the difference is not significant. This result 
does not agree with that found earlier by Thomas 
21et al (2003) , which say there is a significant 
difference. The fact that plasma albumin was 
decreased, but not significantly in these two 
groups supports the report of Burtis and Ashwood 
22(2001)  that plasma values of albumin in normal 
pregnancies, decreased as a result of pregnancy 
induced physiological changes by an average of 
3.4g/dl in late pregnancy. The significantly higher 
plasma uric acid level in second and third 
trimester hypertensive pregnant women than in 
normotensive pregnant women seen in this study 
confirms similar findings of Madazli et al 
23
(2002) . In the plasma, uric acid level is 
significantly higher in three to six days post 
partum hypertensive than three to six days post 
partum normotensive. The high plasma uric acid 
level may have contributed to proteinuria and 
oedema seen in most of the severe hypertensive 
22, 24subjects . 
Vascular endothelial cell dysfunction in 
pre–eclampsia may be caused by uncontrolled 
lipid peroxidative damage of endothelial cell 
membranes as a result of vascular contact with 
placenta–originated circulating peroxidation 
products, and overwhelms the protective 
mechanisms of the antioxidants, which in turn 
may lead to the observed hypertension in these 
pregnant women. Such event may establish a 
cycle leading ultimately to manifestations of 
pre–eclampsia. The phenomenon of significantly 
lower antioxidants in hypertensive pregnant 
women than normotensive pregnant women as 
confirmed in this study; may lead to accumulation 
of free radicals that mediate lipid peroxidation, 
thereby involved in the endothelial damage seen 
25-26in pre-eclampsia . It also confirms the report 
indicating that maternal circulating and placental 
tissue levels and production rates of lipid 
peroxides are increased in pre–eclampsia as 
26-28compared with normal pregnancy . The 
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increase in oxidative stress and lipid peroxidation 
may explain the mechanisms of various clinical, 
biochemical and pathophysiological peculiarities 
of pre–eclampsia. The severity of the pathological 
process determines the clinical manifestation of 
30pre-eclampsia syndrome .  
There is a significant increase in plasma 
concentrations of albumin, catalase and vitamin C 
in both 3-6 days postpartum normotensive and 3-6 
days postpartum hypertensive when compared 
rd
with their matched 3  trimester normotensive 
rd
pregnant women and 3  trimester hypertensive 
pregnant women respectively. Uric acid showed a 
significant decrease. Labor involves expelling of 
the baby and placenta from a woman's womb. 
Since the syndrome disappears after delivery, it 
may further confirm that the fetoplacental unit may 
be the origin of oxygen free radicals and lipid 
peroxides. Since the immune response normally 
comes into play when there is a pathogen or an 
agent which the immune system regards as foreign 
gets into the body, it may be clear that some 
abnormalities may have occurred at the 
fetoplacental level as seen with high activation of 
the immune system, and this could have been the 
onset of the increasing free radical concentration in 
the body. 
The body antioxidants both exogenous and 
endogenous scavenge these free radicals and repair 
small damages they cause. As the pregnancy 
progresses a point is reached when the increased 
free radicals super-cede the antioxidants of the 
body. The increase in oxidative stress might not be 
so important if there was a compensatory increase 
in antioxidant protection, but the opposite occurs, 
since this present study has shown a significant 
decrease in the concentration of antioxidants, a 
finding consistent with those of Mikhail et al, 
9 19(1994) ; Poranen et al, (1996) ; Madazli et al, 
29(1999) , where in pre-eclamptic women, several 
important antioxidants such as vitamin A, C and E, 
erythrocyte levels of thiols and superoxide 
dismutase were reported to be decreased.
In severe cases, the uric acid, with its low water 
solubility, easily becomes deprotonated and in this 
form, it easily combines with sodium ions to form 
sodium urate crystals in subcutaneous tissues, 
known as tophi, it later precipitates leading to 
4
nephropathy and gouty arthritis . When these 
crystals settle at the glomerulus, it provokes 
i m m u n e  r e s p o n s e s  a n d  l e a d s  t o  
glomerulonephritis. All these result in proteinuria 
and oedema. Furthermore, the nephropathy may 
lead to renal sodium retention and or decreased 
filtration surface. These in turn lead to increased 
fluid volume and venous constriction, which 
leads to an increased cardiac output, and further 
increases in blood pressure. This explains why 
with increased proteinuria, there is further 
increase in severity of the pre–eclamptic patient. 
Since there is a decrease in albumin, to maintain 
the blood osmotic balance, water moves to the 
interstitial cell spaces and this is the cause of 
oedema. However, the decrease in plasma 
albumin may not be due to free radicals, but due to 
proteinuria caused by renal complications that 
was not considered in this work. The high uric 
acid could also be due to renal complications. 
Since catalase and vitamin C have no source of 
alteration that could lead to their decrease, other 
than pregnancy, their significant decrease 
confirms significant increases in free radicals in 
PIH when compared with pregnant normotensive 
women, who in turn have higher levels of free 
radicals than non-pregnant normotensive women.
In conclusion this study showed that pregnancy 
generally reduced the concentration of 
antioxidants but vitamin C levels were higher in 
late pregnancy of normotensive women.
Therefore higher levels of vitamin C may protect 
against PIH, further research in this area is 
necessary in our environment.
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Table 1: 
Physical and biochemical parameters in non-
ndpregnant compared to 2  Trimester pregnant 
women 
Groups         Normotensive    Normotensive   Hypertensive   Comparison 
                      Non-pregnant     Pregnant             Pregnant 
                     A (n=15)              B (n=15)            C (n=15)          A  vs  B   B vs C                   
Variable 
Age (years)   28.3±3.8                29.1±4.1            29.5±4.7           NS           NS 
Parity            1.5±1.3                 2.1± 1.2              2.2±1.7            NS           NS 
SBP               108±10.3              107±8.2              194±24.6            NS      <0.001 
DBP              71.0±9.9                68.6±8.8            94.0±7.0          NS     p<0.001 
Uric acid      0.16±0.03            0.194±0.10           0.30±0.11       NS      p<0.022 
Albumin      46.6±6.6               39.0±9.1              39.6±4.8           p<0.027    NS 
Catalase      3.1±0.18               2.7±0.32         1.1±0.30      p<0.018    p<0.0001 
Vitamin C   0.38±0.10             0.11±0.05     0.07±0.03      p<0.0001   p<0.018 
NS= Not Significant 
Table 2 
Comparison of physical and biochemical 
parameters between normotensive and 
rdhypertensive in the 3  Trimester and days 3-6 
postpartum 
Groups         Normotensive    Hypertensive   Comparism 
                      Pregnant            Pregnant 
                       D(n=15)            E (n=15)                             
Variable 
Age (years)   29.0±4.0                33.5±5.7                 NS   
Parity            1.7±1.3                 3.1± 2.3                  NS 
SBP               104±9.7              177±27.1                p<0.001 
DBP              63.0±9.5              107.6±16.4            p<0.001       
Uric acid      0.16±0.03            0.22±0.06              p<0.031         
Albumin      38.8±6.1               36.8±4.6               NS         
Catalase      2.5±0.25               0.86±0.33             p<0.0001               
Vitamin C   0.38±0.10             0.06±0.03             p<0.001 
Days 3-6 Postpartum 
Age (years)   27.3±3.9                27.1±5.4                   NS 
Parity            1.9± 1.6                2.1±2.1                     NS 
SBP            107.0±13.4            160.0±10.5            p<0.001      
DBP            68.0±10.3             101.0±11.0            p<0.001 
Uric acid      0.17±0.03            0.41±0.16             p<0.0001 
Albumin      48.4±2.2              26.5±5.5               p<0.0001 
Catalase      2.9±0.18               1.5±0.44              p<0.0001 
Vitamin C   0.36±0.07             0.10±0.06            p<0.0001 
NS= Not Significant 
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